Hosted on MSN
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
AstraZeneca released full results from two successful late-stage trials on its experimental drug for chronic obstructive ...
Why place a trial in a country where your chance of getting the new medicine to citizens is only 49%?' says AZ's Angela ...
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal, partner and chief market strategist at Cerity Partners, picked AstraZeneca PLC AZN, Last week, Cambridge, U.K.-based AstraZeneca secured ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results